Literature DB >> 22580439

A newly developed noninvasive and mobile pen-shaped meibography system.

Reiko Arita1, Kouzo Itoh, Shuji Maeda, Koshi Maeda, Shiro Amano.   

Abstract

PURPOSE: To examine the usefulness of a newly developed noninvasive mobile pen-shaped meibography system.
METHODS: This study evaluated a newly developed noninvasive mobile pen-shaped meibography system comprising an infrared light-emitting diode as the light source and a highly sensitive complementary metal oxide semiconductor image camera. The images were recorded digitally. The utility of this system was compared with that of the previously developed noncontact infrared meibography system for examination of the upper and lower eyelids in 20 healthy volunteers (range, 2-91 years) and 23 patients with meibomian gland dysfunction, 17 patients with dry eyes who wore contact lenses, and 14 patients with allergic conjunctivitis accompanied by itching.
RESULTS: Using the newly developed noninvasive mobile pen-shaped meibography system, clear images of the meibomian glands were obtained in all age groups. The quality of the images obtained was similar between the two meibography systems. The quantitative analysis of the images obtained showed no statistically significant difference between the two meibography systems.
CONCLUSIONS: The newly developed noninvasive mobile pen-shaped meibography system is a useful tool that provides meibomian gland images of the same quality and quantity as the noncontact meibography system equipped with a slit lamp. This new system is convenient and applicable for examination of meibomian glands in patients of all ages.

Entities:  

Mesh:

Year:  2013        PMID: 22580439     DOI: 10.1097/ICO.0b013e31825425ef

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  14 in total

1.  Meibography: A review of techniques and technologies.

Authors:  Ryan J Wise; Rachel K Sobel; Richard C Allen
Journal:  Saudi J Ophthalmol       Date:  2012-10

2.  Meibomian gland loss due to trabeculectomy.

Authors:  Hideto Sagara; Tetsuju Sekiryu; Hiroki Noji; Masashi Ogasawara; Yukinori Sugano; Hiroko Horikiri
Journal:  Jpn J Ophthalmol       Date:  2014-05-24       Impact factor: 2.447

3.  Grading and baseline characteristics of meibomian glands in meibography images and their clinical associations in the Dry Eye Assessment and Management (DREAM) study.

Authors:  Ebenezer Daniel; Maureen G Maguire; Maxwell Pistilli; Vatinee Y Bunya; Giacomina M Massaro-Giordano; Eli Smith; Pooja A Kadakia; Penny A Asbell
Journal:  Ocul Surf       Date:  2019-04-22       Impact factor: 5.033

4.  Morphological changes in the meibomian glands of patients with phlyctenular keratitis: a multicenter cross-sectional study.

Authors:  Takashi Suzuki; Naoyuki Morishige; Reiko Arita; Shizuka Koh; Tohru Sakimoto; Rika Shirakawa; Kazunori Miyata; Yuichi Ohashi
Journal:  BMC Ophthalmol       Date:  2016-10-10       Impact factor: 2.209

5.  Changes in meibomian gland morphology and ocular higher-order aberrations in eyes with chalazion.

Authors:  Shima Fukuoka; Reiko Arita; Rika Shirakawa; Naoyuki Morishige
Journal:  Clin Ophthalmol       Date:  2017-05-30

6.  Assessment of meibomian gland morphology by noncontact infrared meibography in Shih Tzu dogs with or without keratoconjunctivitis sicca.

Authors:  Yasunari Kitamura; Seiya Maehara; Tetsuya Nakade; Yukihiro Miwa; Reiko Arita; Hiroko Iwashita; Akihiko Saito
Journal:  Vet Ophthalmol       Date:  2019-02-04       Impact factor: 1.644

7.  Efficacy of an artificial tear emulsion in patients with dry eye associated with meibomian gland dysfunction.

Authors:  Christine W Sindt; Gary N Foulks
Journal:  Clin Ophthalmol       Date:  2013-08-27

8.  Objective image analysis of the meibomian gland area.

Authors:  Reiko Arita; Jun Suehiro; Tsuyoshi Haraguchi; Rika Shirakawa; Hideaki Tokoro; Shiro Amano
Journal:  Br J Ophthalmol       Date:  2013-06-27       Impact factor: 4.638

9.  Abnormalities in the meibomian glands in patients with oral administration of anticancer combination drug-capsule TS-1(®): a case report.

Authors:  Shin Mizoguchi; Yuka Okada; Masahide Kokado; Shizuya Saika
Journal:  BMC Cancer       Date:  2015-10-24       Impact factor: 4.430

Review 10.  Non-pharmaceutical treatment options for meibomian gland dysfunction.

Authors:  Reiko Arita; Shima Fukuoka
Journal:  Clin Exp Optom       Date:  2020-01-13       Impact factor: 2.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.